Aurin Biotech Inc.

Canada

 
Quantité totale PI 11
Rang # Quantité totale PI 139 699
Note d'activité PI 1,1/5.0    3
Rang # Activité PI 341 302

Brevets

Marques

6 0
0 0
5 0
0
 
Dernier brevet 2021 - Methods for treating and prevent...
Premier brevet 2011 - Selective inhibition of the memb...

Derniers inventions, produits et services

2021 Invention Methods for treating and preventing nociceptive pain. Methods of treating a condition resulting ...
2019 Invention Kit for treating cancer with low molecular weight components of aurin tricarboxylic acid complex....
2018 Invention Methods for diagnosing and treating cachexia. A method of treating cachexia is provided. The met...
Invention Methods for diagnosing and treating cachexia. A method of treating cachexia is provided. The meth...
Invention Method for treating cancer with low molecular weight components of aurin tricarboxylic acid compl...
2017 Invention Salivary abeta42 levels as prognostic indicators for alzheimer's disease. Methods and kits for a...
Invention Salivary abeta42 levels as prognostic indicators for alzheimer's disease. Methods and kits for ac...
Invention Methods for treating and preventing nociceptive pain. Methods of treating a condition resulting i...
2014 Invention Acetyl salicyclic acid dimers, synthesis thereof, and uses thereof to prevent and treat complemen...
Invention Treatment of age-related macular degeneration. A method of treating age-related macular degenerat...
Invention Treatment of atypical hemolytic uremic syndrome. A method of treating atypical hemolytic uremic ...
2013 Invention Topical treatment of inflammatory skin conditions using a combination of aurin tricarboxylic, aur...
Invention Methods for preventing and treating inflammatory skin conditions. Methods of treating inflammator...
2012 Invention Protection against skin diseases by aurin tricarboxylic acid and its derivatives. This invention ...
Invention Selective inhibition of the membrane attack complex of complement and c3 convertase by low molecu...
2011 Invention Selective inhibition of the membrane attack complex of complement by low molecular weight compone...